Growth Metrics

DBV Technologies (DBVT) Accounts Payables (2015 - 2026)

DBV Technologies (DBVT) reported Accounts Payables of $39.5 million for Q1 2026, up 15.68% year-over-year from $34.1 million in Q1 2025, and down 3.42% on a QoQ basis from $40.9 million in Q4 2025.

DBV Technologies (DBVT) has 12 years of Accounts Payables data on file, last reported at $39.5 million in Q1 2026.

  • Quarterly Accounts Payables rose 15.68% year-over-year to $39.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $39.5 million (up 15.68% YoY) and the FY2025 annual result came in at $40.9 million, up 85.64% from the prior year.
  • Accounts Payables retreated to $39.5 million in Q1 2026 per DBVT's latest filing, from $40.9 million in the prior quarter.
  • Across five years, Accounts Payables topped out at $40.9 million in Q4 2025 and bottomed at $11.4 million in Q1 2022.
  • The 5-year median for Accounts Payables is $19.9 million (2023), against an average of $24.4 million.
  • The widest annual swing landed in 2022, when Accounts Payables plunged 33.54%; it then soared 105.83% in 2025.
  • Tracing DBVT's Accounts Payables over 5 years: stood at $14.5 million in 2022, then soared by 61.0% to $23.3 million in 2023, then fell by 5.45% to $22.0 million in 2024, then jumped by 85.64% to $40.9 million in 2025, then fell by 3.42% to $39.5 million in 2026.
  • Per Business Quant, the three latest DBVT Accounts Payables figures stand at $39.5 million (Q1 2026), $40.9 million (Q4 2025), and $39.8 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Accounts Payables (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - 1.05 Mn
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 83.00 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - 10.62 Mn
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 8.64 Mn
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 489.30 Mn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 1.03 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 126.63 Mn
10 DBV Technologies 8.00 Bn 7.77 Bn -3.90 Mn 39.50 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 39.50 Mn
Dec 31, 2025 40.90 Mn
Sep 30, 2025 39.82 Mn
Jun 30, 2025 40.79 Mn
Mar 31, 2025 34.15 Mn
Dec 31, 2024 22.03 Mn
Sep 30, 2024 22.50 Mn
Jun 30, 2024 19.82 Mn
Mar 31, 2024 18.08 Mn
Dec 31, 2023 23.30 Mn
Sep 30, 2023 16.65 Mn
Jun 30, 2023 19.09 Mn
Mar 31, 2023 19.94 Mn
Dec 31, 2022 14.47 Mn
Sep 30, 2022 15.37 Mn
Jun 30, 2022 16.34 Mn
Mar 31, 2022 11.42 Mn
Dec 31, 2021 11.43 Mn
Sep 30, 2021 12.17 Mn
Jun 30, 2021 16.34 Mn
Mar 31, 2021 17.18 Mn
Dec 31, 2020 20.34 Mn
Jun 30, 2020 24.14 Mn
Dec 31, 2019 23.65 Mn
Sep 30, 2019 -12.09 Mn
Jun 30, 2019 -6.68 Mn
Dec 31, 2018 32.61 Mn
Sep 30, 2018 1.09 Mn
Jun 30, 2018 3.35 Mn
Dec 31, 2017 19.95 Mn
Jun 30, 2017 16.79 Mn
Dec 31, 2016 3.94 Mn
Dec 31, 2015 11.00 Mn